Clarivate Plc CLVT · NYSE
$1.76 -0.56% (-$0.01)
Summary
39 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $224.5M in the last fiscal year, 20% of its market value.
What to watch
- The company made a loss over the last 12 months.
- Repaying its net debt would take 8.4 years of operating profit.
- Revenue fell by 2.6% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 14% a year over 5 years. Over the last 3 years it fell by 2.6% a year.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $334.0M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 13.0 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 6
- Hold 11
- Sell 4
Today's price within the analysts' price targets
The average target of $2 is 14% above today's price. 29% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Recurring Revenues 50%
- Subscription Revenues 39%
- Re-occurring Revenues 11%
By region
- North America 53%
- EMEA 27%
- Asia Pacific 20%
Recurring Revenues brings in 50% of revenue. Subscription Revenues grew fastest, by 12% a year.
Segments in detail